chrisvoncsefalvay/vaers-outcomes huggingface dataset:
May be 28 minutes after taking shot left ring finger top joint felt pain and felt like a slight burn.; May be 28 minutes after taking shot left ring finger top joint felt pain and felt like a slight burn.; When looked at finger, saw the vein popping in upper part of finger vertically. The patient started to rub it because it hurt; When looked at finger, saw the vein popping in upper part of finger vertically. The patient started to rub it because it hurt; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO153), via an unspecified route of administration in the left arm on 06Apr2021 at 11:45 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. Medical history included mild asthma, osteoarthritis in both knees, insomnia, low vitamin d and latex allergy. Concomitant medications included doxylamine succinate (UNISOM), vitamin d nos (VITAMIN D), minerals nos, vitamins nos, xantofyl (KIRKLAND ADULT GUMMIES) and hylan g-f 20 (SYNVISC ONE); all from unknown dates for unspecified indications. The patient previously took rofecoxib (VIOXX), cox-2 drugs for example celecoxib (CELEBREX), aspartame (MANUFACTURER UNKNOWN); all on unknown dates for unspecified indications and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 12:30, the patient waited 15 minutes after receiving shot at pharmacy clinic and may be 28 minutes later after taking the shot, the patient experienced left ring finger top joint felt pain and felt like a slight burn, like when one touch a hot light bulb quickly. When the patient looked at finger, saw the vein popping in upper part of finger vertically. The patient started to rub it because it hurt and 5 to 6 minutes later vein popping went away and most of pain, then may be another minute for all pain to go away. The events did not result in doctor or other health care professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events left ring finger top joint felt pain, vein popping in upper part of finger vertically, started to rub it because it hurt were resolved on 06Apr2021. The clinical outcome of the event felt like a slight burn was resolved on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
1st dose 2017, hasn't gotten the second; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 96-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2017, Dose:0.5 ml, Route of administration: intramuscular, Anatomical location:Unknown).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The case was reported by the patient's daughter. The age at vaccination was not applicable for this report. The patient got her first Shingrix vaccine in 2017 and had not gotten the second, which led to incomplete course of vaccination.  The patient did intend to get the second, but wanted to know how to proceed and spoke per content and referred to healthcare professional . The reporter did not consent to follow-up.
Soreness and aching at the site of injection for the past year. No Rx. Pt received the vaccine at a local store in lobby site.
headache on and off; her equilibrium was completely off, she felt like she was going to trip over; She could not drive; sore shoulder; extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of BALANCE DISORDER (her equilibrium was completely off, she felt like she was going to trip over), IMPAIRED DRIVING ABILITY (She could not drive), ARTHRALGIA (sore shoulder), FATIGUE (extremely tired) and HEADACHE (headache on and off) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No relevant medical history was reported.  Concomitant products included VITAMINS NOS and ALPRAZOLAM for an unknown indication.   On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced ARTHRALGIA (sore shoulder) and FATIGUE (extremely tired). On 20-Feb-2021, the patient experienced BALANCE DISORDER (her equilibrium was completely off, she felt like she was going to trip over) and IMPAIRED DRIVING ABILITY (She could not drive). On an unknown date, the patient experienced HEADACHE (headache on and off). On 19-Feb-2021, ARTHRALGIA (sore shoulder) had resolved. On 20-Feb-2021, FATIGUE (extremely tired) had resolved. At the time of the report, BALANCE DISORDER (her equilibrium was completely off, she felt like she was going to trip over) was resolving and IMPAIRED DRIVING ABILITY (She could not drive) and HEADACHE (headache on and off) outcome was unknown.            No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Reporter provided details about 2nd shot: received 19MAR2021 with "no bad reactions."
I had a bad reaction (stroke) right after my last pneumonia vaccine.; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program.  A 69-year-old male patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration at single dose on an unspecified date for immunisation.   The patient medical history and concomitant medications were not reported.  The patient had a bad reaction (stroke) right after the last pneumonia vaccine on an unspecified date.  The outcome of the event was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Significant pain from should you shoulder abs inability to move neck. Very sore on both sides of top of spine; This is a spontaneous report from a contactable consumer. This 46-year-old female consumer (patient).  A 46-year-old (non-pregnant) female patient received a dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EN6200, Expiration date: unknown), via unspecified route, administered on 17Feb2021 (at the age of 46-year-old) as dose 1, single for COVID-19 immunization. The patient medical history includes Systemic lupus erythematosus, Asthma and Hypothyroidism and concomitant medications includes Levothyroxine, Plaquenil [HYDROXYCHLOROQUINE SULFATE], Fluoxetine, Dupilumab (DUPIXENT, Traz [OMEPRAZOLE]. On 18Feb2021, after the vaccination, the patient experienced Significant pain from should you shoulder abs inability to move neck. Very sore on both sides of top of spine. No other vaccine in four weeks, patient was not diagnosed with covid prior vaccination and patient was not tested with covid post vaccination. The outcome of the events was not recovered.  No follow-up attempts possible. No further information expected.
second dose of shingrix 3 yrs past their first dose; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 0.5 ml 1st dose of Shingrix 3 years ago).   On 10th December 2021, the patient received the 2nd dose of Shingrix .5 ml. On 10th December 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details provided were as follows: Age at vaccination was not reported. The reporter asked if the patient needed a third dose of shingrix if they were past the 6 months for getting the second dose. He stated that he just gave a patient their second dose of shingrix 3 yrs past their first dose, which led to lengthening of vaccination schedule. The reporter had limited information on the patient's demographics and vaccine. The reporter did not consent to follow-up.
Flareup; pain; gout; elevated uric acid levels; it has been a week and he is still bed ridden; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain), GOUT (gout), BLOOD URIC ACID INCREASED (elevated uric acid levels), BEDRIDDEN (it has been a week and he is still bed ridden) and ARTHRITIS (Flareup) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 07-Apr-2021, the patient experienced PAIN (pain), GOUT (gout), BLOOD URIC ACID INCREASED (elevated uric acid levels) and BEDRIDDEN (it has been a week and he is still bed ridden). On an unknown date, the patient experienced ARTHRITIS (Flareup). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN at an unspecified dose and frequency and INDOMETACIN (INDOMETHACIN COX) at an unspecified dose and frequency. At the time of the report, PAIN (pain), GOUT (gout), BLOOD URIC ACID INCREASED (elevated uric acid levels) and ARTHRITIS (Flareup) outcome was unknown and BEDRIDDEN (it has been a week and he is still bed ridden) had not resolved. Not Provided       Patient had no medical issues before with no concomitant medications. Consent received to be contacted by safety.
Awakened by severe chills, body aches, muscle aches, 101 fever.
This spontaneous report as received from an other health professional refers to a 13 month old male patient. On 01-MAY-2013 the patient was vaccinated with the first dose of VARIVAX (dose not reported, lot # H018457, expiration date: 05-OCT-2017 subcutaneously, (SQ), in right thigh (RT)). On 01-MAY-2013 the patient experienced localized redness, large area of swelling 6 x 8cm, very hard and hot and therapy with VARIVAX was not reported. This is one of several reports received from the same source (related MARRS # 1306USA008688). Additional information has been requested.
This spontaneous report received from a health care worker refers to a patient of unknown demographics. No medical history was reported. On 09-SEP-2015 the patient was vaccinated with VARIVAX (lot # K016127, route, dose and frequency: unknown) instead of PROQUAD due to a human error. No adverse effect was reported. No Product Quality Complaints (PQCs) was involved. This is one of the several reports from the same reporter. Additional information has been requested.
3pm shoulder achy, general not feeling well. 545 pm temp 100.8. 715 pm temp 102 took Advil. 4am normal. Felt fine.
Auto-Immune Platelet Condition.. ITP Immune Thrombocytopenia I am reporting this incidence in the hopes it will help in your Covid-19 Vaccine development. My doctors are non-committal at this time, waiting to see.  My story in brief: I received my Pfizer Covid-19 2nd Booster (4th vaccine) on April 20, 2022 (age 81). In preparation for a routine physical, I had a blood test a week later which showed a dangerous drop in platelet level. The lab notified my doctor and I was sent to the Hospital ER immediately on April 28, 2022. My platelet reading was 3,000...down from 250,000 a year ago.  While I remained in the hospital for TEN days, every possible test was performed finding no possible reasons for the extremely low platelet count. CT scans of head, full body scan, bone marrow biopsy...steroids for 5 days not working, platelet infusion failed. Diagnosed with ITP. I was finally put on RITUXIMAB and discharged from the hospital May 8, 2022. I have continued for 6 infusions during the summer months. Platelet count slowly rising.  Since NOTHING was found to contribute to the low platelet scare, I am still wondering if that 4th vaccine (2nd booster) or accumulation caused an overload of sorts to my immune system. If this fits into your research in any way, I am more than willing to cooperate. All of my series of 4 Covid-19 vaccines have been Pfizer.
This case was reported by a pharmacist via call center representative and described the occurrence of blister in a elderly female patient who received SHINGRIX (batch number B9739, expiry date 22nd November 2020) for prophylaxis. Concomitant products included Venlafaxine and Estradiol Patch. On 29th May 2018, the patient received SHINGRIX .5 ml. On an unknown date, less than a month after receiving SHINGRIX, the patient experienced blister. On an unknown date, the outcome of the blister was not recovered/not resolved. The reporter considered the blister to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The pharmacist called about one of her patients at her pharmacy that received the SHINGRIX vaccine at her pharmacy. The floater pharmacist gave the injection to the patient on that day. The patient called over this past weekend and said that she had some blisters on her upper arm on both arms.
febrile 105, face edematous, urticaria on face, ears, upper & lower extremities;
Crook in my neck, feels different; Can barely turn it; This case was reported by a consumer via interactive digital media and described the occurrence of stiff neck in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In June 2022, the patient received Shingles vaccine. In June 2022, less than 2 weeks after receiving Shingles vaccine, the patient experienced stiff neck and mobility decreased. The patient was treated with diclofenac sodium (Voltaren Cream), non-drug therapy (Ice Pack (No Medication)) and non-drug therapy (Heat (Non-Drug Therapy)). On an unknown date, the outcome of the stiff neck and mobility decreased were unknown.   It was unknown if the reporter considered the stiff neck and mobility decreased to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 16-JUN-2022 Reporter's Comment: The patient self-reported this case via interactive digital media. The patient received dose of shingles vaccine two weeks ago and he/she noticed that he/she now thought he/she had a crook in his/her neck but it felt different. The patient could barely turn it after putting ice and heat on it and valtarin cream. The patient didn't think about it until last night. Additional supportive information: The follow-up would not possible, as no contact, details were available.
65-66 YO with splenectomy was recommended Hiberix; This case was reported by a pharmacist via call center representative and described the occurrence of drug prescribing error in a elderly male patient who received Hib (Hiberix) for prophylaxis.   Previously administered products included Hiberix (received 2 doses on an unknown date ). Concurrent medical conditions included splenectomy.   On an unknown date, the patient received Hiberix. On an unknown date, unknown after receiving Hiberix, the patient experienced drug prescribing error. On an unknown date, the outcome of the drug prescribing error was unknown.   Additional Information: GSK receipt date: 26-Aug-2022 Reporter's comment: The pharmacist reported that he had the patient who was around 65-66 years old who underwent splenectomy and was recommended to receive Hiberix.  The reporter did not obtained permission for follow-up. Additional supportive information: The patient was recommended to receive Hiberix when the patient underwent splenectomy, which led to drug prescribing error.
I developed a trigger thumb in my left hand, and I had surgery for it. In late December 2021 I had muscle tightness in both upper leg muscles which is my inner thigh muscles. I started having severe muscle tightness in my legs and severe hip pain. The doctor is telling me that it's severe arthritis. It progressed super fast. I used to walk 2 to 4 miles a day 5 days a week and now I can barely walk without pain. I did have an injection of Prolia on 12/23/2021 for my osteoporosis. I'm still in severe pain and barely able to walk.
No additional adverse effect reported; Caller stated that GARDASIL 9 that underwent a temperature excursion was administered.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 03-MAY-2021, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection in prefilled syringe, lot # 1691180, expiration date: 15-NOV-2022 (exact dose, injection site and route of administration were not provided) for prophylaxis.  The administered vaccine experienced a temperature excursion of 9 degrees Celsius to 25 degrees Celsius (9.92 degrees Celsius) for 1 hour and 21 minutes. The digital data logger was involved in recording the temperature excursion details. No previous temperature excursion had occurred. No adverse effects were reported.  This is one of three reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.  devicelotnumber: 1691180; expirationdate: 15-NOV-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2105USA000845: US-009507513-2105USA000846:
FATHER REPORTED TO PHONE NURSE ON 9/29/16 THAT PATIENT WAS EXTREMELY FATIGUED, SEVERE HEADACHE, SEVERE NECK PAIN WITH STIFFNESS, AND SEVERE BACK PAIN. PT DIRECTED TO ER FOR CHECK ON SYMPTOMS BEING REPORTED.
Information has been received from a health professional concerning a 13 year old male student with an allergy to ampicillin who on 12-MAR-1996 (year to be clarified) was vaccinated with varicella virus vaccine live (Oka/Merck) (lot # 608578/0389B) in the left arm at 10:50 am. There were no previous doses given and no concomitant therapy reported. It was reported that the patient developed more than 50 lesions which did not require treatment. The patient recovered on 24-MAR-2007. Additional information has been requested.
Localized arm pain that developed into a large, hard, hot lump that was very painful. Lump dissipated and turned into a large raised and itchy rash. By 01/23/2021 the rash had spread over my chest and other limbs. The rash is extremely itchy. Saw Provider on 01/26/21 and she determined that the rash was from the Covid vaccine and ordered a steroid injection to get the rash under control.
Patient was given regular Pfizer instead of the Pediatric Pfizer.  Presumed dose of 0.2ml.  Patient's mother states normal side effects from Covid vaccine with low grade fever and a whelp at injection site.  No other events.
sore arm at the injection site after the first dose; headache after the first dose; Moderna COVID-19 vaccine administered to a patient under 18 years old; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna COVID-19 vaccine administered to a patient under 18 years old), VACCINATION SITE PAIN (sore arm at the injection site after the first dose) and HEADACHE (headache after the first dose) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna COVID-19 vaccine administered to a patient under 18 years old). On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm at the injection site after the first dose) and HEADACHE (headache after the first dose). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. On 09-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Moderna COVID-19 vaccine administered to a patient under 18 years old) had resolved. At the time of the report, VACCINATION SITE PAIN (sore arm at the injection site after the first dose) and HEADACHE (headache after the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The nurse reported  patient under the age of 18 years old receiving the first dose of Moderna COVID-19 vaccine on 9Apr2021 and the second dose of Moderna COVOD-19 vaccine on 7May2021. Nurse stated the patient complained of sore arm at the injection site and  headache after the first dose.
Pediatric dose instead of the adult dose; Pediatric dose instead of the adult dose; This case was reported by a other health professional via call center representative and described the occurrence of underdose in a 37-year-old female patient who received HBV (Engerix B pediatric) (batch number 77X47, expiry date 22nd December 2023) for prophylaxis.   On 7th March 2022, the patient received the 1st dose of Engerix B pediatric (intramuscular). On 7th March 2022, unknown after receiving Engerix B pediatric, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   Additional Information: GSK Receipt Date: 5-APR-2022 Reporter's Comment: HCP (Health care professional) was calling on behalf of an employee who received the pediatric dose of Engerix B instead of the adult dose. This occurred on 7th March 2022 but was just discovered today (on the day of reporting). The health care professional reporting the event does not have the patient's HCP information so no contact information was able to be provided. The reporter did not consent to follow-up. Additional supportive information:  The patient received the pediatric dose of Engerix B instead of the adult dose, which led to underdose and adult use of a child product.
This spontaneous report as received from a nurse, a health care worker refers to patients of unknown age and gender. The patient's concurrent conditions and medical history were not reported. The reporter stated that on an unspecified date, the patients were vaccinated with improperly stored PROQUAD (Merck) Lot # L033692 EXP: 28-FEB-2017 (unknown how many). No adverse effects reported. No product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Constant ringing in ears since 8 Apr 21.  Phantom smell (green onions) for two weeks 10 - 24 Apr 21 (approximate dates)
After shot given, was sore. Shot given possibly to high. It has been over a month now pain spreads to fingers. Right hand.
Gastrointestinal: Nausea, diarrhea (foul smelling), cramping, lower abdominal pain, fatigue, chills, headache